Kan Z. Gianattasio, MPP; Ali Moghtaderi, PhD; Dale Lupu, PhD; et al.
open access
JAMA Health Forum. 2022;3(5):e220900. doi:10.1001/jamahealthforum.2022.0900
This cross-sectional study examines the association of hospice use among patients with Alzheimer disease and related dementias with the passage of the US IMPACT Act and implementation of the 2-tier payment system.
Matthew E. Barclay, PhD; Mary Dixon-Woods, DPhil; Georgios Lyratzopoulos, MD
open access
JAMA Health Forum. 2022;3(5):e221006. doi:10.1001/jamahealthforum.2022.1006
This cross-sectional study aims to identify the changes in hospital ratings and rankings associated with alternative methodological choices in the calculation of the 2021 Centers for Medicare & Medicaid Services Hospital Compare star ratings.
Yang Wang, BS; Ge Bai, PhD, CPA; Gerard Anderson, PhD
open access
JAMA Health Forum. 2022;3(5):e221018. doi:10.1001/jamahealthforum.2022.1018
This cross-sectional study examines changes in the operational financial performance and overall financial viability of US hospitals during the COVID-19 pandemic.
Ravi Gupta, MD; Christopher J. Morten, JD, PhD; Angela Y. Zhu, PhD; et al.
open access
JAMA Health Forum. 2022;3(5):e221096. doi:10.1001/jamahealthforum.2022.1096
This cross-sectional study examines whether new formulations of brand-name novel drugs were associated with novel drugs’ sales and/or therapeutic value as well as characterizes new formulations’ approval timing relative to the novel drug’s generic approval.
Eveline A. M. Heijnsdijk, PhD; Roman Gulati, MS; Jane M. Lange, PhD; et al.
open access
JAMA Health Forum. 2022;3(5):e221116. doi:10.1001/jamahealthforum.2022.1116
This decision analytical model of prostate cancer screening programs in the Bahamas evaluates the projected benefit of limited screening programs and the implied resources required for their sustainable implementation.
Joshua J. Skydel, MD; Alexander C. Egilman, BA; Joshua D. Wallach, PhD, MS; et al.
open access
has audio
JAMA Health Forum. 2022;3(5):e221158. doi:10.1001/jamahealthforum.2022.1158
This cross-sectional study evaluates spending by the Centers for Medicare & Medicaid on drugs granted FDA accelerated approval before and after confirmation of benefit from 2012 to 2017 with follow-up through 2020.
-
Podcast:
Prescription Drug Cost Provisions of the Inflation Reduction Act
Jeannie P. Cimiotti, PhD; Edmund R. Becker, PhD; Yin Li, PhD; et al.
open access
JAMA Health Forum. 2022;3(5):e221173. doi:10.1001/jamahealthforum.2022.1173
This cross-sectional study examines the association of registered nurse workload with mortality in Medicare beneficiaries admitted to an acute care hospital with sepsis.
Ryan D. Chow, PhD; Elizabeth H. Bradley, PhD; Cary P. Gross, MD
open access
JAMA Health Forum. 2022;3(5):e221229. doi:10.1001/jamahealthforum.2022.1229
This cross-sectional study assesses whether cancer mortality rates in 2020 were lower in countries with higher cancer-related spending and estimates across countries the incremental cost per averted cancer death.